Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014122956> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2014122956 endingPage "358" @default.
- W2014122956 startingPage "353" @default.
- W2014122956 abstract "To determine if enzyme replacement therapy, involving intravenous infusions of recombinant human alpha-galactosidase A (agalsidase beta; Fabrazyme), could be safely continued in patients with Fabry disease who had been withdrawn from a previous clinical trial as a precautionary, protocol-specified measure due to detection of serum IgE antibodies or skin-test reactivity to agalsidase beta.The rechallenge infusion protocol specified strict patient monitoring conditions and graded dosing and infusion-rate schemes that were adjusted according to each patient's tolerance to the infusion. Six males (age: 26-66 years) were enrolled.During rechallenge, five patients received between 4 and 27 infusions; one patient voluntarily withdrew after one infusion because of recurrence of infusion-associated reactions. No anaphylactic reactions occurred. All adverse events, including four serious adverse events, were mild or moderate in intensity. Most treatment-related adverse events occurred during infusions (most commonly urticaria, vomiting, nausea, chills, pruritus, hypertension) and were resolved by infusion rate reductions and/or medication. After participation in the study, all patients, including the one who withdrew after one infusion, transitioned to commercial drug.Agalsidase beta therapy can be successfully reinstated in patients with Fabry disease who have developed IgE antibodies or skin test reactivity to the recombinant enzyme." @default.
- W2014122956 created "2016-06-24" @default.
- W2014122956 creator A5011464526 @default.
- W2014122956 creator A5039205256 @default.
- W2014122956 creator A5041853032 @default.
- W2014122956 creator A5047033639 @default.
- W2014122956 creator A5053307455 @default.
- W2014122956 creator A5075757755 @default.
- W2014122956 date "2008-05-01" @default.
- W2014122956 modified "2023-10-13" @default.
- W2014122956 title "Successful reinstitution of agalsidase beta therapy in Fabry disease patients with previous IgE-antibody or skin-test reactivity to the recombinant enzyme" @default.
- W2014122956 cites W1483242733 @default.
- W2014122956 cites W2000846576 @default.
- W2014122956 cites W2012946336 @default.
- W2014122956 cites W2026893678 @default.
- W2014122956 cites W2030054541 @default.
- W2014122956 cites W2041953538 @default.
- W2014122956 cites W2067825423 @default.
- W2014122956 cites W2125879510 @default.
- W2014122956 cites W2136689144 @default.
- W2014122956 cites W2313827278 @default.
- W2014122956 cites W2405202058 @default.
- W2014122956 doi "https://doi.org/10.1097/gim.0b013e318170f868" @default.
- W2014122956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18496035" @default.
- W2014122956 hasPublicationYear "2008" @default.
- W2014122956 type Work @default.
- W2014122956 sameAs 2014122956 @default.
- W2014122956 citedByCount "40" @default.
- W2014122956 countsByYear W20141229562012 @default.
- W2014122956 countsByYear W20141229562013 @default.
- W2014122956 countsByYear W20141229562014 @default.
- W2014122956 countsByYear W20141229562015 @default.
- W2014122956 countsByYear W20141229562017 @default.
- W2014122956 countsByYear W20141229562018 @default.
- W2014122956 countsByYear W20141229562020 @default.
- W2014122956 countsByYear W20141229562021 @default.
- W2014122956 countsByYear W20141229562022 @default.
- W2014122956 crossrefType "journal-article" @default.
- W2014122956 hasAuthorship W2014122956A5011464526 @default.
- W2014122956 hasAuthorship W2014122956A5039205256 @default.
- W2014122956 hasAuthorship W2014122956A5041853032 @default.
- W2014122956 hasAuthorship W2014122956A5047033639 @default.
- W2014122956 hasAuthorship W2014122956A5053307455 @default.
- W2014122956 hasAuthorship W2014122956A5075757755 @default.
- W2014122956 hasBestOaLocation W20141229561 @default.
- W2014122956 hasConcept C126322002 @default.
- W2014122956 hasConcept C141071460 @default.
- W2014122956 hasConcept C141105273 @default.
- W2014122956 hasConcept C159654299 @default.
- W2014122956 hasConcept C197934379 @default.
- W2014122956 hasConcept C203014093 @default.
- W2014122956 hasConcept C2777288759 @default.
- W2014122956 hasConcept C2777404818 @default.
- W2014122956 hasConcept C2778594517 @default.
- W2014122956 hasConcept C2779134260 @default.
- W2014122956 hasConcept C2779969927 @default.
- W2014122956 hasConcept C2780580376 @default.
- W2014122956 hasConcept C2780852908 @default.
- W2014122956 hasConcept C42219234 @default.
- W2014122956 hasConcept C71924100 @default.
- W2014122956 hasConceptScore W2014122956C126322002 @default.
- W2014122956 hasConceptScore W2014122956C141071460 @default.
- W2014122956 hasConceptScore W2014122956C141105273 @default.
- W2014122956 hasConceptScore W2014122956C159654299 @default.
- W2014122956 hasConceptScore W2014122956C197934379 @default.
- W2014122956 hasConceptScore W2014122956C203014093 @default.
- W2014122956 hasConceptScore W2014122956C2777288759 @default.
- W2014122956 hasConceptScore W2014122956C2777404818 @default.
- W2014122956 hasConceptScore W2014122956C2778594517 @default.
- W2014122956 hasConceptScore W2014122956C2779134260 @default.
- W2014122956 hasConceptScore W2014122956C2779969927 @default.
- W2014122956 hasConceptScore W2014122956C2780580376 @default.
- W2014122956 hasConceptScore W2014122956C2780852908 @default.
- W2014122956 hasConceptScore W2014122956C42219234 @default.
- W2014122956 hasConceptScore W2014122956C71924100 @default.
- W2014122956 hasIssue "5" @default.
- W2014122956 hasLocation W20141229561 @default.
- W2014122956 hasLocation W20141229562 @default.
- W2014122956 hasOpenAccess W2014122956 @default.
- W2014122956 hasPrimaryLocation W20141229561 @default.
- W2014122956 hasRelatedWork W186628991 @default.
- W2014122956 hasRelatedWork W1963806491 @default.
- W2014122956 hasRelatedWork W1983060250 @default.
- W2014122956 hasRelatedWork W2024467157 @default.
- W2014122956 hasRelatedWork W2025323739 @default.
- W2014122956 hasRelatedWork W2043774580 @default.
- W2014122956 hasRelatedWork W2054676974 @default.
- W2014122956 hasRelatedWork W2067330669 @default.
- W2014122956 hasRelatedWork W2107083873 @default.
- W2014122956 hasRelatedWork W2164951759 @default.
- W2014122956 hasVolume "10" @default.
- W2014122956 isParatext "false" @default.
- W2014122956 isRetracted "false" @default.
- W2014122956 magId "2014122956" @default.
- W2014122956 workType "article" @default.